Novo Nordisk’s Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage

That decision could widen insurance coverage for the drug and similar treatments for obesity, which has been a major barrier to access for patients.

Previous post Memecoin price forecast: can it keep up with the memecoins frenzy as the likes of Kangamoon rise
Next post Spacecraft maker Terran Orbital ‘looking at everything,’ CEO says after Lockheed Martin takeover bid